NSE: ZYDUSWELL | BSE: 531335

Mid-range Performer

Download real time

416.70 -8.55 (-2.01%)

39.53% Gain from 52W Low

207.1K NSE+BSE Volume

NSE 20 Jan, 2026 3:31 PM (IST)

13,257.8

Market Cap

High in industry

Beta 1Year

Very Low volatility

Zydus Wellness Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for ZYDUSWELL, BSE:531335 Zydus Wellness Ltd.

Search Inside the pdf :

Zydus Wellness Ltd.

31 Dec 2025

416.70

-2.01%

Scaling up the wellness brand equity

Buy: Zydus Wellness Ltd.

Motilal Oswal

Zydus Wellness is a diversified health and nutrition company (~INR40bn revenue) with leadership in several consumer wellness categories. The company’s core portfolio consists of sugar substitutes (Sugar Free), glucose powders (Glucon-D), skincare (Everyuth), functional foods (Nutralite), prickly-heat powder (Nycil), and nutritional beverages (Complan).

Zydus Wellness Ltd. has an average target of 562.50 from 6 brokers.

Zydus Wellness Ltd.

06 Nov 2025

416.70

-2.01%

Soft patch; synergy play unfolding

Buy: Zydus Wellness Ltd.

ICICI Securities Limited

Zydus Wellness (Zydus)’s Q2FY26 was a strategically important yet transitional quarter – strategic in direction but impacted by muted organic momentum amid GST-led disruption and seasonal weakness.

Zydus Wellness Ltd. is trading below all available SMAs

Zydus Wellness Ltd.

03 Sep 2025

416.70

-2.01%

Comfort Click acquisition paves way for higher global presence

Buy: Zydus Wellness Ltd.

Target

Sharekhan

Zydus Wellness Limited (ZWL) has acquired 100% stake in Comfort Click Ltd (CCL), which operates in UK and major European markets. This marks ZWL’s first overseas acquisition and its entry into the Vitamins, Minerals and Supplements (VMS) segment.

Zydus Wellness Ltd. has an average target of 562.50 from 6 brokers.

Zydus Wellness Ltd.

02 Sep 2025

416.70

-2.01%

Comfort Click acquisition is earnings accretive; Buy

Buy: Zydus Wellness Ltd.

Target

Anand Rathi

Zydus’ acquisition of UK-based Comfort Click broadens its footprint across the UK, EU and USA. The transaction positions it to scale up its wellness range globally, a strategic step toward building a diversified, consumer-focused beauty, health & wellness portfolio.

Zydus Wellness Ltd. has an average target of 562.50 from 6 brokers.

Zydus Wellness Ltd.

05 Aug 2025

416.70

-2.01%

Soft Q4

Buy: Zydus Wellness Ltd.

Target

Sharekhan

ZWL’s Q1FY26 numbers were soft, with muted revenue growth and lower margins that dragged down PAT. Consolidated revenue grew by 2.4% y-o-y to Rs. 861 crore, in line with our expectation of Rs. 858 crore.

Zydus Wellness Ltd. has an average target of 562.50 from 6 brokers.

Zydus Wellness Ltd.

05 Aug 2025

416.70

-2.01%

Soft Q4

Buy: Zydus Wellness Ltd.

Target

Sharekhan

Zydus Wellness Ltd. is trading below all available SMAs

Zydus Wellness Ltd.

21 May 2025, 12:00AM

416.70

-2.01%

BP Equities Q4FY25 Result Update Zydus Wellness Ltd

Results Update: Zydus Wellness Ltd.

BP Wealth

Zydus Wellness Ltd. is trading below all available SMAs

Zydus Wellness Ltd.

13 Feb 2025

416.70

-2.01%

Mixed bag Q3

Buy: Zydus Wellness Ltd.

Target

Sharekhan

Zydus Wellness Limited’s (ZWL’s) Q3FY25 numbers were mixed with revenue beating estimates and growing by 14.6% y-o-y to Rs. 462 crore (versus expectation of Rs. 435 crore), while OPM stood flat y-o-y at 3.1% and missed expectations of 5.8%. Volume growth stood at 4.8%.

Zydus Wellness Ltd. is trading below all available SMAs

Zydus Wellness Ltd.

05 Feb 2025

416.70

-2.01%

Zydus Wellness (HOLD): Margin focus over reinvestments

Hold: Zydus Wellness Ltd.

Target

BOB Capital Markets Ltd.

Q3FY25 sales came in 2% above consensus while EBITDA was 2% lower due to 15bps lower-than-expected margins

Zydus Wellness Ltd. is trading below all available SMAs

Zydus Wellness Ltd.

11 Nov 2024

416.70

-2.01%

Mixed bag Q2

Buy: Zydus Wellness Ltd.

Target

Sharekhan

Zydus Wellness Limited’s (ZWL’s) Q2FY2025 numbers were mixed with revenue growing by 12% y-o-y to Rs. 493 crore (versus Rs. 475 crore expected), while OPM stood flat y-o-y at 4% (against expectation of 5.3%). Adjusted PAT came in at Rs. 16 crore.

Zydus Wellness Ltd. is trading below all available SMAs

Is Zydus Wellness Ltd. worth buying?

151 Votes:

Buy 78.15%

Sell 11.26%

Hold 10.6%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf